COVID-19 IgG/IgM Rapid Test

Product Information
Description

Catalog:	C0244T
Product Type:	Rapid test
Unit:	30 tests
Tested parameter:	SARS-COV-2, IgG, IgM
Assay time:	15 min
Sample type:	serum, plasma or whole blood
Sensitivity:	97.1%
Specificity:	97.8%
Test type:	Qualitative
Application:	COVID-19

COVID-19 IgG/IgM rapid detection is a single-use lateral flow immunoassay rapid detection method for qualitative detection and identification of anti-SARS in human serum, plasma or whole blood containing EDTA, heparin or citric acid anticoagulant -CoV-2 IgG and IgM antibodies. The current laboratory method for detecting SARS-CoV-2 infection is RT-PCR. SARS-CoV-2 specific antibodies are effective markers for immune response and epidemiological investigations.

Diagnostic Development

About Us

Creative Bioarray is an innovative biotechnology company whose mission is developing unique technologies that provide global scientists with high quality products and satisfactory services to facilitate the investigation of life science researches.

Diagnostics Development

Oncology Hematology Respiratory Disease Autoimmune Disease Gastrointestinal Disease Endocrine Disease Liver Disease Infectious Disease Sexually Transmitted Diseases Tropical Diseases

Core Diagnostic Capabilities

Flow Cytometry Enzyme-linked Immunoassay Chemiluminescence Immunoassay Molecular Diagnosis

Contact Us

USA

Tel:

Fax:

Email:

Europe

Tel:

Email: